English | Español
Patient Daily | Apr 9, 2026

Science Correspondent Bailey on vaccine liability: 'As history amply shows, exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines. Americans...
Patient Daily | Apr 9, 2026

Taxpayers Protection Alliance Executive Director Marchand on vaccine injury table: 'Adding autism to VICP's vaccine injury table would represent one of the biggest giveaways to trial lawyers in...
Patient Daily | Apr 8, 2026

Pastor resumes ministry after first Cytalux lung cancer surgery at Northwestern Medicine
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'
Patient Daily | Apr 8, 2026

Breathe Free Teams Pack Meals at Community Volunteer Event, Expanding Care Beyond Clinics
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
Patient Daily | Apr 7, 2026

FDA proposes new clinical trial pathway to accelerate drug development timelines
Patient Daily | Apr 6, 2026

FDA reversals on external controls in rare disease trials raise questions for drug developers

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
Patient Daily | Apr 8, 2026

Breathe Free Teams Pack Meals at Community Volunteer Event, Expanding Care Beyond Clinics
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'